Benefit of Enhanced Contact Endoscopy in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal Lesions

NCT ID: NCT04777474

Last Updated: 2022-12-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-15

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The focus of the study is to verify the role of enhanced contact endoscopy in early identification of high-risk vascular patterns of precancerous and malignant mucosal changes in ear-nose-throat (ENT) patients, in comparison with other standard imaging techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Endoscopy methods are inseparable part in diagnostics of patients with head and neck cancer. Nowadays ENT surgeons are offered a wide variety of endoscopy methods. The methods that caused revolution in early diagnostics of head and neck cancer were advanced imagining endoscopy methods such as NBI or IMAGE1S.

The new only recently introduced method is enhanced contact endoscopy, which uses a combination of advanced imagining, such as NBI or IMAGE1S, with rigid microlaryngoscope. It is believed that this technology has the potential to visualise vascular patterns of precancerous and malignant mucosal changes even better than narrow-band imaging (NBI) and IMAGE1S. This improvement in diagnostics helps with early identification of high-risk lesions and moves us closer to the concept of pre-histological diagnostics, which helps to accelerate making final diagnosis, which leads to prompt treatment.

Study protocol:

* anamnestic questionnaire (age, sex, weight, height, smoking, alcohol, reflux disease)
* Reflux Symptom Index (RSI) questionnaire
* endoscopy in white light in local anaesthesia with evaluation:
* character of the lesion (benign, Reinke edema, cyst, polyp, chronic laryngitis/pharyngitis, leukoplakia, erythroplakia, malignity)
* bleeding or ulceration on the surface of the lesion
* endoscopy with NBI endoscope in local anesthesia with evaluation:
* mucosa vascularization according to the ELS classification
* size of the lesion in compare to endoscopy in white light in local anesthesia
* occurrence of new lesions in compare to endoscopy in white light in local anesthesia
* endoscopy in white light in general anesthesia during microlaryngoscopy
* character of the lesion (benign, Reinkes edema, cyst, polyp, chronic laryngitis/pharyngitis, leukoplakia, erythroplakia, malignity)
* bleeding or ulceration on the surface of the lesion
* size of the lesion in compare to endoscopy in white light in local anesthesia
* occurence of new lesions when compared with endoscopy in white light in local anesthesia
* endoscopy in NBI or IMAGE1S in general anesthesia during microlaryngoscopy
* mucosa vascularization according to the ELS classification
* size of the lesion in compare to endoscopy in white light in local anesthesia
* occurence of new lesions in compare to endoscopy in white light in local anesthesia
* enhanced contact endoscopy (ECE) in NBI or IMAGE1S in general anesthesia during microlaryngoscopy
* mucosa vascularization according to the ELS and Puxxedu classification
* size of the lesion in compare to endoscopy in white light and NBI/ IMAGE1S in general anesthesia
* occurence of new lesions in compare to endoscopy in white light and NBI/

IMAGE1S in general anesthesia

* histology examination with determination of final diagnosis
* benign lesion
* mild dysplasia
* severe dysplasia
* carcinoma in situ
* invasive cancer

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laryngeal Disease Laryngeal Lesions Hypopharyngeal Lesions Suspected Laryngeal Cancer Suspected Hypopharyngeal Cancer Proven Laryngeal Cancer Proven Hypopharyngeal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

The study subjects will be enrolled into one study group.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

No masking is being used in the study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enhanced contact endoscopy

The study subjects will undergo enhanced contact endoscopy

Group Type EXPERIMENTAL

Enhanced contact endoscopy

Intervention Type DIAGNOSTIC_TEST

The study subjects will undergo enhanced contact endoscopy - studied imaging technique

Narrow band imaging

Intervention Type DIAGNOSTIC_TEST

The study subjects will undergo narrow band imaging - comparator procedure

IMAGE1S imaging

Intervention Type DIAGNOSTIC_TEST

The study subjects will undergo IMAGE1S imaging - comparator procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enhanced contact endoscopy

The study subjects will undergo enhanced contact endoscopy - studied imaging technique

Intervention Type DIAGNOSTIC_TEST

Narrow band imaging

The study subjects will undergo narrow band imaging - comparator procedure

Intervention Type DIAGNOSTIC_TEST

IMAGE1S imaging

The study subjects will undergo IMAGE1S imaging - comparator procedure

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and older
* patients scheduled for direct hypopharyngoscopy and laryngoscopy in general anaesthesia
* benign laryngeal and hypoharyngeal disease/laryngeal and hypopharyngeal lesions of uncertain biologic behaviour (leukoplakia, erythroplakia, keratosis)
* patients with suspicious macroscopical lesion found during ENT examination/patients with histologically confirmed metastasis of carcinoma in neck lymph node with unknown primary origin of the tumour
* patients with recurrence of malign tumour in hypopharynx or larynx
* patients after radiotherapy indicated for follow up examination under general anaesthesia
* patients with persistent non-specific problems (hoarseness, swallowing problems etc.) indicated to direct laryngohypopharyngoscopy due to diagnostic purposes

Exclusion Criteria

* age - younger than 17 years
* refusal to join the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Ostrava

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Kántor, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ostrava

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

Site Status RECRUITING

University Hospital Hradec Králové

Hradec Králové, , Czechia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jiří Hynčica

Role: CONTACT

0042059737 ext. 2587

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jiří Hynčica

Role: primary

0042059737 ext. 2587

Anna Švejdová, MD

Role: primary

0042049583 ext. 3 221

References

Explore related publications, articles, or registry entries linked to this study.

Puxeddu R, Sionis S, Gerosa C, Carta F. Enhanced contact endoscopy for the detection of neoangiogenesis in tumors of the larynx and hypopharynx. Laryngoscope. 2015 Jul;125(7):1600-6. doi: 10.1002/lary.25124. Epub 2015 Jan 13.

Reference Type BACKGROUND
PMID: 25582112 (View on PubMed)

Mehlum CS, Dossing H, Davaris N, Giers A, Grontved AM, Kjaergaard T, Moller S, Godballe C, Arens C. Interrater variation of vascular classifications used in enhanced laryngeal contact endoscopy. Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2485-2492. doi: 10.1007/s00405-020-06000-z. Epub 2020 Apr 30.

Reference Type BACKGROUND
PMID: 32350646 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23/RVO-FNOs/2020

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

23/RVO-FNOs/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Magnifying NBI for Occult NPC
NCT04593186 UNKNOWN NA
EMR Versus ESD for Barrett's Neoplasia
NCT05276791 NOT_YET_RECRUITING NA